Crowdonomics
NowRx

NowRx Preferred Equity 1

ClosedReg A+Preferred Equity
via SeedInvestView campaign
Raised
$28.4M / $75M max
38% of ceiling
Investors
—
—
Post-money valuation
$303.4M
pre-money + amount raised

Raised over time

Cumulative raisedInvestors
$26.3M$13.2M$0
6.5K3.3K0
Aug 25, 2021 · openedMay 20, 2022 · last reading
$25.0M raised — May 19, 2022

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via SeedInvest; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2020 · hover for source
$13.4M
−$10.4M
FY2020
RevenueNet income
Metric
FY2020
Income statement
Revenue
$13,414,400
Cost of goods sold
$11,932,203
Gross margin
11%
Net income
-$10,423,845
Balance sheet
Cash
$8,873,706
Accounts receivable
$1,156,705
Total assets
$13,554,205
Long-term debt
$1,939,638
Total liabilities
$4,507,303
Other
Headcount
82

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

1 amendment
  1. Sep 27, 2021
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

Pre-money$275M
Post-money$303.4M
Price / share$10.85
Shares offered6,912,442

Offering details

Target—
Max$75,000,000
Min investment$998
OpenedAug 25, 2021
Deadline—
ClosedMay 18, 2022
Days active266

Links & provenance

Campaign pageSEC filing
Source: Manual
0001104659-21-102906

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.